Article
Programmed Cell Death Ligand 1 Expression in Cytological and Surgical Non-Small Cell Lung Cancer Specimens in Association with EGFR Mutation and Overall Survival: A Single-Institution Experience.
Turk patoloji dergisi - 1 Jan 2022
Gokal Elif Sayman, Aker Fugen Vardar, Silav Zuhal Kus, Oven Bala Basak
Abstract excerpt
OBJECTIVE: The aim of this study was to evaluate programmed cell death ligand-1 (PD-L1) expression and the relationship between driver mutations and survival analysis in advanced-stage non-small cell lung carcinoma (NSCLC). MATERIAL AND METHOD: A total of 122 advanced-stage NSCLC patients were included in this retrospective study. The patients were diagnosed based on cytological examination and histopathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.